Astellas and Pfizer Announce Positive Top-Line Results

PFE: Astellas Pharma Inc.
2018-12-20 09:00:00
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate